🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Immunotherapy has revolutionized cancer treatment, but UChicago Medicine physician experts Ralph Weichselbaum and Sean Pitroda caution that it’s not a one-size-fits-all treatment for metastatic disease. uchicagomedicine.org/forefront/canc…

uchicagomedicine.org/forefront/canc…

.Ralph Weichselbaum & colleagues review the immune response to #radiotherapy-induced anti-tumor effects, & the combination of immune checkpoint blockade w/ radiotherapy hubs.la/Q02KkFR50 From our Mechanisms & Models of #Cancer Collection: hubs.la/Q02KjVGB0 #cshlcancer24

Check out our multi-center phase 2 IIT currently accruing for upfront SBRT added to Durvalumab-based chemoimmunotherapy for the first line treatment of extensive stage SCLC - the DARES trial. Christine Bestvina Docace911 clinical-lung-cancer.com/article/S1525-…

Where does #immunotherapy stand in the treatment of metastatic cancers? Is it the only and best choice? Check out the insights shared by University of Chicago Radiation Oncology experts Ralph Weichselbaum and Sean Pitroda, M.D. here: ow.ly/e1rh50SYn8i UChicago Medicine UChicagoCancerCenter University of Chicago Hematology/Oncology

Kudos to Ralph Weichselbaum and colleagues on publishing an excellent article in Journal of Clinical Investigation demonstrating enhanced antitumor immunity with inhibition/deletion of m6A reader YTHDF1. UChicagoCancerCenter University of Chicago Radiation Oncology UChicago Chemistry Ludwig Cancer ow.ly/jWBh50TxaTa

Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation Out on Lancet Oncology sciencedirect.com/science/articl… A recent workshop organized by the National Cancer Institute, Immuno-Oncology

Facts and hopes in radioimmunotherapy of oligometastatic disease aacrjournals.org/clincancerres/… Excellent review by University of Chicago Radiation Oncology residents Daniel Huang and Connor Lynch Ralph Weichselbaum UChicagoCancerCenter

🔥 Hot off the press: Ralph Weichselbaum, MD, and his team published a new study in nature demonstrating that high-dose radiation to primary tumors can unexpectedly promote tumor growth at metastatic sites. Ralph Weichselbaum Andras Piffko University of Chicago Radiation Oncology uchicagomedicine.org/forefront/canc…

Radiation-induced amphiregulin drives tumor metastasis nature Ralph Weichselbaum Andras Piffko Sean Pitroda, M.D. nature.com/articles/s4158…

Radiation-induced amphiregulin drives tumour metastasis nature.com/articles/s4158…